GDGabriele Dall’aGlio
Gabriele Dall’aGlio
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gabriele Dall’aGlio has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Federica Cruciani
Department of Engineering for Innovation Medicine, University of Verona
1 shared publication - Gloria Menegaz
University of Verona
1 shared publication - Ilaria Boscolo Galazzo
University of Verona
1 shared publication - Lorenza Brusini
Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy
1 shared publication Mauro Zucchelli
Department of Research and Development Advanced Applications, Olea Medical, La Ciotat, France
1 shared publication- Tommaso Zajac
Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy
1 shared publication
Latest Publications
- Open Access
- 17 July 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Translational Engineering in Health and Medicine
- Vol. 12, 569-579
XAI-Based Assessment of the AMURA Model for Detecting Amyloid-β and Tau Microstructural Signatures in Alzheimer’s Disease
Brain microstructural changes already occur in the earliest phases of Alzheimer’s disease (AD) as evidenced in diffusion magnetic resonance imaging (dMRI) literature. This study investigates the potential of the novel dMRI Apparent Measures Using Reduced Acquisitions (AMURA) as imaging markers for capturing such tissue modifications.Tract-based spatial statistics (TBSS) and support vector machines (SVMs) based on different measures were exploited to distinguish between amyloid-beta/tau negative (A$\beta $ -/tau-) and A$\beta $ +/tau+ or A$\beta $ +/tau- subjects. Moreover, eXplainable Artificial Intelligence (XAI) was used to highlight the most influential features in the SVMs classifications and to validate the results by seeing the explanations’ recurrence across different methods.TBSS analysis revealed significant differences between A$\beta $ -/tau- and other groups in line with the literature. The best SVM classification performance reached an accuracy of 0.73 by using advanced measures compared to more standard ones. Moreover, the explainability analysis suggested the results’ stability and the central role of the cingulum to show early sign of AD.By relying on SVM classification and XAI interpretation of the outcomes, AMURA indices can be considered viable markers for amyloid and tau pathology. Clinical impact: This pre-clinical research revealed AMURA indices as viable imaging markers for timely AD diagnosis by acquiring clinically feasible dMR images, with advantages compared to more invasive methods employed nowadays.- 17 July 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Translational Engineering in Health and Medicine
- Vol. 12, 569-579
Open AccessXAI-Based Assessment of the AMURA Model for Detecting Amyloid-β and Tau Microstructural Signatures in Alzheimer’s Disease
Brain microstructural changes already occur in the earliest phases of Alzheimer’s disease (AD) as evidenced in diffusion magnetic resonance imaging (dMRI) literature. This study investigates the potential of the novel dMRI Apparent Measures Using Reduced Acquisitions (AMURA) as imaging markers for capturing such tissue modifications.Tract-based spatial statistics (TBSS) and support vector machines (SVMs) based on different measures were exploited to distinguish between amyloid-beta/tau negative (A$\beta $ -/tau-) and A$\beta $ +/tau+ or A$\beta $ +/tau- subjects. Moreover, eXplainable Artificial Intelligence (XAI) was used to highlight the most influential features in the SVMs classifications and to validate the results by seeing the explanations’ recurrence across different methods.TBSS analysis revealed significant differences between A$\beta $ -/tau- and other groups in line with the literature. The best SVM classification performance reached an accuracy of 0.73 by using advanced measures compared to more standard ones. Moreover, the explainability analysis suggested the results’ stability and the central role of the cingulum to show early sign of AD.By relying on SVM classification and XAI interpretation of the outcomes, AMURA indices can be considered viable markers for amyloid and tau pathology. Clinical impact: This pre-clinical research revealed AMURA indices as viable imaging markers for timely AD diagnosis by acquiring clinically feasible dMR images, with advantages compared to more invasive methods employed nowadays.